润都股份(002923.SZ)：缬沙坦氨氯地平片(I)获得药品注册证书

Group 1 - The core point of the article is that Rundu Co., Ltd. has received a drug registration certificate from the National Medical Products Administration for Valsartan Amlodipine Tablets, which are indicated for the treatment of primary hypertension [1] Group 2 - The drug is intended for patients whose blood pressure cannot be adequately controlled with monotherapy [1]